BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31471631)

  • 1. Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?
    Bozkaya Y; Köstek O; Sakin A; Özyükseler DT; Şakalar T; Çil İ
    Support Care Cancer; 2020 May; 28(5):2273-2282. PubMed ID: 31471631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer.
    Ikeya T; Shibutani M; Maeda K; Sugano K; Nagahara H; Ohtani H; Hirakawa K
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):307-13. PubMed ID: 25124497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer.
    Go SI; Jeon H; Park SW; Kang MH; Kim HG; Lee GW
    Thorac Cancer; 2018 Nov; 9(11):1483-1491. PubMed ID: 30209884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma.
    Broggi MS; Patil D; Baum Y; Nieh PT; Alemozaffar M; Pattaras JG; Ogan K; Master VA
    Urology; 2016 Oct; 96():99-105. PubMed ID: 27431662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.
    Bozkaya Y; Kurt B; Gürler F
    Int J Clin Oncol; 2019 Jul; 24(7):798-806. PubMed ID: 30783810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy.
    Yoshida R; Gohara S; Sakata J; Matsuoka Y; Hirosue A; Kawahara K; Kawaguchi S; Nagao Y; Yamana K; Nagata M; Fukuma D; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
    Transl Oncol; 2020 Dec; 13(12):100850. PubMed ID: 32854035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
    Zhang Y; Kong FF; Zhu ZQ; Shan HX
    BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.
    Berardi R; Rinaldi S; Santoni M; Newsom-Davis T; Tiberi M; Morgese F; Caramanti M; Savini A; Ferrini C; Torniai M; Fiordoliva I; Bower M; Cascinu S
    Oncotarget; 2016 May; 7(18):26916-24. PubMed ID: 27029035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma.
    Xu Y; Yuan X; Zhang X; Hu W; Wang Z; Yao L; Zong L
    Medicine (Baltimore); 2021 Jun; 100(25):e26506. PubMed ID: 34160470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of Onodera's index in colorectal cancer survival].
    Borda F; Borda A; Zozaya JM; Urman J; Jiménez J; Ibáñez B
    An Sist Sanit Navar; 2014; 37(2):213-21. PubMed ID: 25189979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy.
    Chantharakhit C; Sujaritvanichpong N
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1149-1156. PubMed ID: 33906307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Onodera's prognostic nutritional index (OPNI) a prognostic factor in small cell lung cancer (SCLC)?
    Yenibertiz D; Ozyurek BA; Erdogan Y
    Clin Respir J; 2020 Aug; 14(8):689-694. PubMed ID: 32170830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomogram based on pre-treatment HALP score for patients with advanced non-small cell lung cancer.
    Gao S; Huang Q; Wei S; Lv Y; Xie Y; Hao Y
    Clinics (Sao Paulo); 2024; 79():100371. PubMed ID: 38735175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.
    Yılmaz A; Tekin SB; Bilici M; Yılmaz H
    Lung; 2020 Aug; 198(4):695-704. PubMed ID: 32424800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.
    Vanhove K; Mesotten L; Heylen M; Derwael R; Louis E; Adriaensens P; Thomeer M; Boellaard R
    Cancer Treat Res Commun; 2018; 15():7-12. PubMed ID: 30207286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Clinical Prognostic Score to Predict Survival of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Receiving First-Line Chemotherapy: A Retrospective Analysis.
    Gong J; Xu L; Li Z; Hu X; Liu J; Teng Y; Jin B; Zhao M; Shi J; Guo T; Shi X; Cheng Y; Liu Y; Qu X
    Med Sci Monit; 2018 Nov; 24():8264-8271. PubMed ID: 30446633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy.
    Ying J; Zhou D; Gu T; Huang J; Liu H
    BMC Cancer; 2019 Mar; 19(1):288. PubMed ID: 30925910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.